DIFFERENT PROCEDURE, LANGUAGE LEADS TO DIFFERENT RESULTS by Johnston Cope Alan & Celniker I. Craig
The Mock Trial was a fascinating cultural and legal experience in which we are grateful to
have had the opportunity to participate. When asked for our impression of the proceedings, one
thing immediately came to mind: In order to ensure that justice is being done, Japan and the United
States have adopted legal procedures that are very different from one another. It is therefore not
surprising that in some instances the application of these systems will lead to different results. The
particular case that was used for the Mock Trial was excellent for demonstrating these differences.
Observing the Japanese trial in the morning, it is evident that the Japanese process is very
methodical, analytical and detail oriented. Each issue in the case was examined by the panel of
Tokyo District Court Judges sequentially and in detail with argument from the parties exhausted
before moving on to the next issue. The methodical resolution of each issue results in an outcome
that is “fair and correct” because the process is applied consistently to everyone and necessarily and
inexorably leads to a decision that is by definition correct because it is the result of a fair and rea-
soned process. In the Japanese Mock Trial, after examining each of the other issues, the court con-
cluded that the act of making the heparin outside of the syringe and then placing it into the syringe
was an essential part of the invention. Once that decision was made, the outcome was determined.
There could be no infringement either literally or by equivalents.
The US trial appears quite different. At the trial, US trial lawyers focus directly on convincing
the jury as to what is the overall “fair” result, consistent with the legal instructions that the judge will
give the jurors. All issues may not be addressed in detail. Some may not be addressed at all. Because
the jurors may lack technical training, the technology at issue is likely to be described in general
terms, and the jury is expected to understand it more by analogy to everyday, known things rather
than as a scientist or technical expert would understand the technology. Instead, great attention is
devoted to the big picture or “telling the story” so that the jury gets a direct sense of the “fair” out-
come. 
In addition to focusing on the big picture, a U.S. trial lawyer must also give the jury a way,
consistent with the judge’s anticipated instructions on the law and the meaning of the claim terms, to
reach the result that the trial lawyer hopefully has convinced the jury is the “fair” outcome. In the US
case at the Mock Trial, the jury was convinced that the main idea of plaintiff – freeze-drying a solu-
tion of water soluble filler and heparin so that a reproducible, uniformly distributed and readily man-
ufacturable unit dose of heparin could be applied to a blood sample – was taken by defendant so that
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the “right” or “fair” result would be to require defendant to pay the plaintiff for plaintiff’s essential
contribution. The path that was given to the jurors so that they could find in favor of plaintiff was to
make them understand that they were free to find that the differences between the plaintiff’s patent
and the defendant’s product or process were “insubstantial” (i.e. “equivalent”) which would allow
them to reach the result that they wanted to reach – even if those differences took defendant’s prod-
uct or process outside the literal scope of plaintiff’s patent.
Thus, the “fairness” issue is approached more indirectly in the Japanese procedure. By consis-
tently following a fair procedure, the result must be fair, or at least very likely will be. In contrast, the
American procedure addresses the “fairness” issue more directly. The reasoning in the American
system is that, if an advocate in an adversary system is capable of convincing 12 jurors to unanimous-
ly conclude that a given outcome is fair or right (and consistent with the judge’s instructions on the
law and meaning of the claims), then it must be fair, or at least very likely will be.
The differences in the two approaches can be viewed as somewhat of a necessary or obvious
consequence of the different characteristics of the persons chosen to be the triers of fact in the two
systems. In the US system, lay people, usually with no legal or technical background, are the triers of
fact. Therefore, detailed presentation of complex issues may bore or frustrate rather than convince.
In contrast, the Japanese judges who try the case are experienced jurists and often have technical
backgrounds or the ability to understand technical matters. As such they are much more likely not
only to be open to detailed factual and legal argument, but to actually require argument at that level
of sophistication to be convinced.
Looking at the two systems from the point of view of the “trial” only, however, may give an
exaggerated view of the differences between them. While a Japanese trial occurs over several ses-
sions spread out over several months, a US trial usually occurs in one continuous block of time at the
end of the case. However, many months are spent preparing the groundwork for a U.S. trial, and dur-
ing that time, many of the complex and detailed arguments that appear to be missing from a US trial
are made to the Judge and the results incorporated into the structure of the trial. For example, the
US Judges usually conduct a hearing – often well before the trial – on the proper construction of the
patent claims (Markman Hearing). That hearing is usually marked by several days of complex techni-
cal testimony and complex legal and technical argument which results in a claim construction that is
incorporated into the instructions to the jury as to what exactly it is that they need to find in order to
find infringement. Similarly, many of the issues that the Japanese court dealt with during the open-
ing stages of the trial are disposed of in the US by motions to the court made prior to the trial – and
those issues are then excluded from the trial, for example by a summary judgment motion.
Moreover, the US attorney’s ability to focus the trial on big picture, “fairness” issues is also
constrained by the fact that the verdict will have to withstand the scrutiny of a Federal Circuit
appeal if there is an appeal from the trial court’s decision. Thus, attorneys must confine their argu-
ments about what is fair to the framework of legal principles enunciated by the Federal Circuit. The
Federal Circuit Justices are experienced jurists with a very deep and nuanced understanding of the
principles of patent law and with backgrounds that allow them to broadly and deeply understand the
technology at issue in the case. Therefore, much of the discipline present in the Japanese system
that seems to be lacking from the US trial is actually supplied by the preliminary work of the District
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Court Judge leading up to the trial and, if necessary, by the Federal Circuit Justices on appeal after
the trial.
An additional observation is the extent to which language differences can play a crucial role in
the case outcome. In the original patent application at issue in the Mock Trial, which was filed in the
US, the claim required that the pledget be “placed in” the syringe. This term is broad in meaning and
can encompass the act of placing the pledget within the syringe as well as taking it from the outside
of the syringe and putting it into the syringe. The Japanese patent application translated “placed in”
with the Japanese term “ireru” which translates in English roughly as “inserted in” or “placed into”,
a slightly narrower term that apparently encompasses only those situations where the pledget is
taken from outside the syringe and put inside. 
Since the defendant in this case actually manufactured the pledget in place in the syringe, it is
clear that the defendant’s activities could not fall literally within the terms of the Japanese patent,
but could be understood to fall literally within the terms of the US patent. Indeed the jurors in the
U.S. Mock Trial reported that they were split evenly, six to six, on the question of whether defendant
literally infringed the US patent. In the Japanese case, no serious attempt was even made to argue
literal infringement. Plaintiff conceded there was no literal infringement in its complaint.  This differ-
ence in the closeness of the product or process to the literal terms of the patent undoubtedly was a
strong factor – if only psychologically – in the different conclusions reached by the Japanese panel of
judges and the jurors on the issue of infringement under the doctrine of equivalents. Put another
way, the difference between defendant’s process and plaintiff’s patent certainly seems much less
substantial when a good faith argument can be made that, notwithstanding the differences, the
defendant’s process still falls within the literal claims of the patent. It is therefore helpful to be able
to put on a credible literal infringement case, even if one intends ultimately to rely on infringement
by doctrine of equivalents.
Because patent cases are, at their core, about language and the nuanced meanings of words
and combinations of words in the patent claims, the litigation of the same invention and the same
product in different nations using different languages inherently risks different results because
translations are not likely to be perfectly equivalent. Whether the translation issue arises during the
patent prosecution process or during litigation, even slightly different meanings can have a profound
effect on the outcome. The Mock Trial amply illustrated this principal and the importance of devot-
ing appropriate resources to make sure that part of the invention is not “lost in translation.”
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